Diabetes UK Grant Funding News

Submitted by pgmcintosh on Tue, 17/11/2009 - 09:59

Diabetes UK is committed to funding new research that has the potential to improve the lives of people living with diabetes. This year, despite the harsh economic climate, we have made new awards through all of our funding routes: PhD Studentships, Basic and Clinical Fellowships, Small grants, Equipment grants and Project grants in addition to maintaining a portfolio of existing research grants representing a total value of awards of around £20 million.

Tags:

Read more

Patient & Public Involvement Strategy

Submitted by pgmcintosh on Fri, 06/11/2009 - 11:02

The background to this strategy is a commitment by the Scottish Topic-Specific Research Networks (Primary Care, Diabetes, Stroke, Medicines for Children, Mental Health & Dementia) to ensure that patients, those who care for them and the public are actively involved in all aspects of the research process, including shaping the direction of Research Network development.

Tags:

Read more

Glargine Press Release

Submitted by pgmcintosh on Mon, 29/06/2009 - 13:26

Following concerns raised by another paper in Diabetologia the EASD asked a team of researchers in Scotland (the Scottish Diabetes Research Network – Epidemiology group) to examine the question of cancer risk in insulin glargine users in Scotland.

Using anonymised patient data linked to the Scottish Cancer Registry Data we were able to show that insulin glargine users as a whole do not have an altered risk of all cancers combined or any of the main cancers, including breast cancer. This is reassuring news.

Tags:

Read more

Use of insulin glargine and cancer incidence in Scotland

Submitted by pgmcintosh on Mon, 15/06/2009 - 15:01

Aims/hypothesis
The aim of the present study was to examine whether patients with diabetes in Scotland using insulin glargine have a greater cancer risk than patients using other types of insulin.

Tags:

Read more